Specialist in Endocrinology and Metabolic Diseases with extensive training in radioiodine therapy. Currently practicing at Gaziantep Özel Defa Life Hospital.
Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.
Team Leader in Surgical Endocrinology at Vienna General Hospital (AKH), focusing on endocrine surgery with specialized expertise in thyroid conditions.
Dr. Mucahit Gur specializes in thyroid diseases at Emsey Hospital, offering personalized radioiodine therapy.
Dr. Pastrana is a board-certified surgical oncologist specializing in radioiodine therapy at Galenia Hospital.
Dr. Tamer Atasever brings 34 years of experience of nuclear medicine expertise to Medipol Mega University Hospital, specializing in radioiodine therapy.
Specializes in radioiodine therapy with over 34 years of experience of experience in internal medicine, currently practicing at Medipol Acibadem Hospital.
Prof. Dr. Özgen specializes in pediatric endocrine disorders, with extensive expertise in managing thyroid conditions through radioiodine therapy at Biruni University Hospital.
Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.
Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.
Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.
He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.
Dr. Sadir Alrawi is a board-certified surgical oncologist. He specializes in upper gastrointestinal, head and neck, minimally invasive, breast, and colorectal cancers. He also has expertise in heated chemoperfusion. Dr. Alrawi serves as the Director of Oncology Services at VPS Hospital system in the UAE and MENA region. He oversees several tertiary referral cancer centers.
Dr. Alrawi holds both American and British board certifications. He completed fellowships at Roswell Park Cancer Institute. He has previously led oncology divisions at Al Zahra Hospital, Tawam Hospital (a Johns Hopkins affiliate), and 21st Century Oncology in Florida. Dr. Alrawi has published widely and given many invited talks. He remains active in oncology research and education.
Dr. Shruti Kate specializes in treating advanced cancers with immunotherapy and metronomic therapy – presenting her lung cancer research at the World Conference on Lung Cancer.
Dr. Ahmer Arif Shaikh brings 15 years of experience of specialized experience in surgical oncology, focusing on radioiodine therapy at HCG Manavata Cancer Centre.
Dr. Jun Won Kim is a dedicated oncologist at Severance Hospital, specializing in radioiodine therapy.
Prof. Engin brings decades of expertise in radiation oncology, including specialized training at the National Cancer Institute and Thomas Jefferson University.
30 years of experience of surgical oncology experience with 50,000+ cancer surgeries performed – Dr. Raj specializes in breast and thoracic oncology at HCG Manavata Cancer Centre.
Dr. Shaunak Valame specializes in radioiodine therapy with a strong focus on targeted cancer treatments. His research on stomach cancer was presented at the American Society of Clinical Oncology symposium.
Dr. Lalit Banswal has performed over 10,000 major surgeries with a focus on minimally invasive cancer techniques, ensuring excellent outcomes.